Hypothermia after Perinatal Asphyxia Does Not Affect Genes Responsible for Amyloid Production in Neonatal Peripheral Lymphocytes
- PMID: 35743334
- PMCID: PMC9225259
- DOI: 10.3390/jcm11123263
Hypothermia after Perinatal Asphyxia Does Not Affect Genes Responsible for Amyloid Production in Neonatal Peripheral Lymphocytes
Abstract
In this study, the expression of the genes of the amyloid protein precursor, β-secretase, presenilin 1 and 2 by RT-PCR in the lymphocytes of newborns after perinatal asphyxia and perinatal asphyxia treated with hypothermia was analyzed at the age of 15-21 days. The relative quantification of Alzheimer's-disease-related genes was first performed by comparing the peripheral lymphocytes of non-asphyxia control versus those with asphyxia or asphyxia with hypothermia. In the newborns who had perinatal asphyxia, the peripheral lymphocytes presented a decreased expression of the amyloid protein precursor and β-secretase genes. On the other hand, the expression of the presenilin 1 and 2 genes increased in the studied group. The expression of the studied genes in the asphyxia group treated with hypothermia had an identical pattern of changes that were not statistically significant to the asphyxia group. This suggests that the expression of the genes involved in the metabolism of the amyloid protein precursor in the peripheral lymphocytes may be a biomarker of progressive pathological processes in the brain after asphyxia that are not affected by hypothermia. These are the first data in the world showing the role of hypothermia in the gene changes associated with Alzheimer's disease in the peripheral lymphocytes of newborns after asphyxia.
Keywords: Alzheimer’s disease; amyloid protein precursor; brain ischemia; genes; hypothermia; hypoxic-ischemic encephalopathy; lymphocytes; perinatal asphyxia; presenilin 1 and 2; β-secretase.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Preservation of Biomarkers Associated with Alzheimer's Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia.Int J Mol Sci. 2023 Aug 27;24(17):13292. doi: 10.3390/ijms241713292. Int J Mol Sci. 2023. PMID: 37686098 Free PMC article.
-
Alzheimer's Disease Associated Presenilin 1 and 2 Genes Dysregulation in Neonatal Lymphocytes Following Perinatal Asphyxia.Int J Mol Sci. 2021 May 13;22(10):5140. doi: 10.3390/ijms22105140. Int J Mol Sci. 2021. PMID: 34067945 Free PMC article.
-
Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.J Alzheimers Dis. 2024;98(1):151-161. doi: 10.3233/JAD-231333. J Alzheimers Dis. 2024. PMID: 38393914 Free PMC article.
-
Hypoxic-Ischemic Brain Injury after Perinatal Asphyxia as a Possible Factor in the Pathology of Alzheimer’s Disease.In: Pluta R, editor. Cerebral Ischemia [Internet]. Brisbane (AU): Exon Publications; 2021 Nov 6. Chapter 4. In: Pluta R, editor. Cerebral Ischemia [Internet]. Brisbane (AU): Exon Publications; 2021 Nov 6. Chapter 4. PMID: 34905310 Free Books & Documents. Review.
-
Hypothermia therapy for newborns with hypoxic ischemic encephalopathy.J Pediatr (Rio J). 2015 Nov-Dec;91(6 Suppl 1):S78-83. doi: 10.1016/j.jped.2015.07.004. Epub 2015 Sep 4. J Pediatr (Rio J). 2015. PMID: 26354871 Review.
Cited by
-
Preservation of Biomarkers Associated with Alzheimer's Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia.Int J Mol Sci. 2023 Aug 27;24(17):13292. doi: 10.3390/ijms241713292. Int J Mol Sci. 2023. PMID: 37686098 Free PMC article.
-
Melatonin: A Potential Candidate for the Treatment of Experimental and Clinical Perinatal Asphyxia.Molecules. 2023 Jan 22;28(3):1105. doi: 10.3390/molecules28031105. Molecules. 2023. PMID: 36770769 Free PMC article. Review.
References
-
- Balada R., Tebé C., León M., Arca G., Alsina M., Castells A.A., Alcántara S., Garcia-Alix A. Enquiring beneath the surface: Can a gene expression assay shed light into the heterogeneity among newborns with neonatal encephalopathy? Pediatr. Res. 2020;88:451–458. doi: 10.1038/s41390-020-0764-2. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources